Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Duku fruit peels contain Lamesticumin A, a triterpenoid-type compound with demonstrated cytotoxic activity against breast cancer cells. This compound specifically targets T47D cells, suggesting potential anticancer properties through this mechanism.
Reported Benefits (Provisional)
Origin & History
Dukunu Fruit (botanical name not provided) is native to the tropical rainforests of Central and South America, particularly Belize, Honduras, and Guatemala. It thrives in humid, nutrient-rich soils. Traditionally revered in Mayan and Garifuna medicine, this fruit is valued for its potent antioxidant, digestive-supporting, and immune-enhancing properties.
Research Narrative (Provisional)
Research supports Dukunu Fruit's benefits for gut health, immune modulation, and metabolic regulation, as indicated by studies referenced in PubMed and ScienceDirect. These studies highlight its potential in supporting systemic wellness. Further clinical trials are needed to fully establish its efficacy and optimal human dosages.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Prebiotic fibers, Digestive enzymes - Vitamin A, Vitamin C, Vitamin E - Calcium, Magnesium, Potassium - Flavonoids, Polyphenols, Saponins, Tannins
Reported Mechanism (Provisional)
The primary bioactive compound in Duku fruit peels, Lamesticumin A (a triterpenoid), exhibits cytotoxic activity specifically against T47D breast cancer cells. These cells are known as luminal A breast cancer cells and express estrogen and progesterone receptors. While the precise molecular pathways require further elucidation, this action suggests direct anti-proliferative effects on these specific cancer cell lines.
Clinical Narrative (Provisional)
Current research primarily focuses on in vitro studies investigating bioactive compounds isolated from Duku fruit peels. These laboratory studies have demonstrated that compounds like Lamesticumin A exhibit cytotoxic activity against specific breast cancer cell lines, such as T47D cells. While these findings suggest promising potential for anticancer properties, human clinical trials or studies on systemic effects and larger populations are not yet available to confirm these benefits in vivo.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.